Next-Generation Sequencing (NGS) is opening new avenues for epigenetic research by unleashing mechanisms that shape cell- and disease-specific gene expression programs. Although technical challenges still exist, having NGS technologies featuring simple workflow, high-throughput capability, and a high-quality readout with minimal sequencing depth will help to enable further breakthroughs.
In this webinar, Dr. Wilfred van IJcken describes and discusses a newly developed method for genome-wide detection of DNA methylation.
This webinar covers the following topics:
- Background on DNA methylation
- Key aspects of the novel MeD-Seq method
- Validation data of MeD-Seq
- Real showcase on cervical cancer after hrHPV infection
Wilfred van IJcken, PhD
Methylomics, Board member and Manager of Erasmus Center for Biomics